Literature DB >> 24295655

Pathology of tracheal tumors.

Klaus Junker1.   

Abstract

Malignant involvement of the trachea predominantly results from direct spread of neighboring tumors to the tracheal wall. Primary tracheal malignancies show a low incidence of approximately 0.1 in every 100,000 persons per year, squamous cell carcinomas and adenoid cystic carcinomas accounting for about two-thirds of adult primary tracheal tumors. The etiology of squamous cell carcinoma and its premalignant lesions is strongly associated with tobacco smoking. Patients with tracheal malignancies show an unfavorable prognosis, with reported 5- and 10-year survival rates of 5% to 15% and 6% to 7%, respectively, for all types of tracheal carcinoma.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma; Epithelial precursor lesions; Pathology; Squamous cell carcinoma; Tracheal tumors

Mesh:

Year:  2014        PMID: 24295655     DOI: 10.1016/j.thorsurg.2013.09.008

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  17 in total

1.  Overview of malignant tracheal tumors.

Authors:  Maria Lucia L Madariaga; Henning A Gaissert
Journal:  Ann Cardiothorac Surg       Date:  2018-03

Review 2.  Airway compromise due to adenoid cystic carcinoma obstructing the distal trachea: a review of current management and clinical trials.

Authors:  Philip Charlton; Lisa Pitkin
Journal:  BMJ Case Rep       Date:  2015-01-14

Review 3.  Tracheal resection and reconstruction for malignant disease.

Authors:  Federico Rea; Andrea Zuin
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

Review 4.  Primary small cell cancer of cervical trachea: a case report and literature review.

Authors:  Jun Qiu; Wei Lin; Min-Li Zhou; Shui-Hong Zhou; Qin-Ying Wang; Yang-Yang Bao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  3D-printing aided resection of intratracheal adenoid cystic carcinoma and mediastinal mature cystic teratoma in a 26-year-old female: a case report.

Authors:  Di Lu; Siyang Feng; Xiguang Liu; Xiaoying Dong; Mei Li; Hua Wu; Pengfei Ren; Dingwei Diao; Kaican Cai
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

6.  The rare cancer network: ongoing studies and future strategy.

Authors:  Mahmut Ozsahin; René-Olivier Mirimanoff; Juliette Thariat; Xu Shan Sun; Banu Atalar; Yasmin Lassen-Ramshad; Gamze Ugurluer; Sunil Krishnan; Christopher Hallemeier; Paul Van Houtte; Marco Krengli; Lan Jun Zhang; Kenneth Chang; Ryan Funk; Jessica Rooney; Robert C Miller
Journal:  Rare Tumors       Date:  2014-08-08

7.  Spindle cell sarcomatoid carcinoma of the trachea: first case report of surgical resection.

Authors:  Juan P Gurria; David M De Acosta; Niloufar Hafezi; Eman B Yousif; Ehab AlAmeer; Richard C Anderson
Journal:  J Cardiothorac Surg       Date:  2016-08-05       Impact factor: 1.637

8.  Sarcomatoid carcinoma in the trachea: A case report and literature review.

Authors:  Si-Hyong Jang; Hyun D Cho; Ji-Hye Lee; Hyun J Lee; Soon A Hong; Junhun Cho; Ho S Lee; Mee-Hye Oh
Journal:  Thorac Cancer       Date:  2017-03-30       Impact factor: 3.500

9.  Extracorporeal membrane oxygenation (ECMO)-assisted intratracheal tumor resection and carina reconstruction: A safer and more effective technique for resection and reconstruction.

Authors:  Yang Qiu; Qiao Chen; Wei Wu; Shixin Zhang; Meng Tang; Ya Chen; Chao Zhang; Ni Zhou; Nan Jiang; Jianping Feng; Mei Xia; Haidong Wang
Journal:  Thorac Cancer       Date:  2019-02-19       Impact factor: 3.500

10.  Coexistence of squamous cell tracheal papilloma and carcinoma treated with chemotherapy and radiotherapy: a case report.

Authors:  Dimitrios Paliouras; Apostolos Gogakos; Thomas Rallis; Fotios Chatzinikolaou; Christos Asteriou; Georgios Tagarakis; John Organtzis; Kosmas Tsakiridis; Drosos Tsavlis; Athanasios Zissimopoulos; Ioannis Kioumis; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis; Paul Zarogoulidis; Nikolaos Barbetakis
Journal:  Ther Clin Risk Manag       Date:  2015-12-21       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.